Biotricity (OTCQB: BTCY) is a healthcare technology company heavily concentrated on establishing innovative wearable medical devices. The devices deliver biometric remote monitoring solutions.
Recently, the company had demonstrated its revolutionary Internet of Things (IoT) wearable medical device at AT&T (NYSE: T)’s Technology Expo event that resulted in both companies becoming partners. AT&T will be providing connectivity to Biotricity’s medical devices. The company has also developed a solution known as Bioflux, and will be delivered by the end of 2016 which will allow physicians to remotely monitor patients’ heart health.
Steve Burger, AVP of Business Development and Connected Health at AT&T IoT Solutions said, “IoT will support a new generation of medical devices capable of transmitting data on an ongoing basis that help push care outside of the hospital and allow for continuous care virtually wherever the patients goes. By wireless enabling [of] their devices, Biotricity will help enable caregivers and healthcare institutions to use their patients’ data in near real-time to make informed and timely decisions.” Wearable medical devices has a promising future as it will help improve in home care, preventive care, and others.
Trending On the News
“It seems that the IoT will play a crucial role in Biotricity’s future, as the company aims to deliver remote biometric monitoring solutions for both chronic conditions and general lifestyle improvement. The global market for the Internet of Things is anticipated to reach $1.7 trillion by 2020. With an ever-growing number of connected devices appearing across a range of sectors, AT&T’s bet on Biotricity and its upcoming Bioflux solution looks to be a solid one,” said Lulu Chang of DigitalTrends.
“AT&T has a holding of $5.2 billion in bonds outstanding. It will put the windfall and is likely to get from cheaper debt to good use, as this is a company that is always on the lookout for where to innovate next. Biotricity is one area the mobile telephony company is looking at, judging by a recent partnership with Biotricity, a medical-diagnostic and consumer-health-care Tech Company,” stated Antonia Oprita from TheStreet.
“AT&T’s “internet of things” business has won a high-profile health care customer. The company is preparing to launch a product called bioflux, which will enable physicians to remotely monitor patients’ heart health in real time. The solution uses a small cellular radio to transmit data,” reported by Martha Degrasse of RCRWirelessNews.